In mice, hepatic development begins at the six-to eightsomite stage of embryogenesis (E8.0) in response to inductive signals from the heart and septum transversum, including fibroblast growth factors and bone morphogenetic proteins, as well as the presence of endothelial cells (9, 15, 17, 24, 40, 45) . In addition to growth factors, gene-targeting studies have implicated several transcription factors in controlling distinct aspects of hepatogenesis (8) (9) (10) . These include the homeobox factor Hex, which is necessary for morphogenesis and growth of the liver bud; Prox1, which is required for hepatoblast migration; and HNF4, which is essential for hepatocyte differentiation and the epithelial transformation of the liver (1, 19, 22, 23, 33, 41) .
Molecular and genetic analyses have suggested that the GATA factors may also act to control hepatogenesis (2, 36, 38, 39, 44, 46, 47) . The GATA family of zinc finger transcription factors currently consists of six members in mammals (34) . GATA1, -2, and -3 appear to act primarily in hematopoietic cells while GATA4, -5, and -6 are expressed in a diverse array of tissues (25) . In vivo footprinting analyses of pluripotent embryonic gut endoderm revealed that GATA4 bound the Albumin (Alb1) enhancer prior to the onset of albumin expression in the primary liver bud, implying a role for GATA4 in regulating the onset of hepatic mRNA expression (2, 3, 5, 7, 15) . Genetic evidence supporting a requirement for GATA factors in development of the gastrointestinal tract and its derivatives, including the liver, has emerged from studies with multiple model systems: GATA5 has been implicated in gut and liver development in zebra fish (37, 38) , END1 is required for endoderm development in Caenorhabditis elegans (46, 47) , SERPENT is essential for gut development in Drosophila melanogaster (36, 39) , and GATA6 contributes to branching morphogenesis of the lungs (18, 43) .
Of the known GATA proteins, GATA6 is a particularly appealing candidate for a factor that may contribute toward liver development because GATA6 regulates expression of the nuclear hormone receptor HNF4 (16, 22, 27, 33) . Moreover, development of Gata6 Ϫ/Ϫ embryos arrests during gastrulation with a phenotype that is very similar to that associated with Hnf4 Ϫ/Ϫ embryos, which is consistent with GATA6 acting upstream of HNF4 during development (4, 20, 27) . This early embryonic lethality, which is believed to be a consequence of extraembryonic endoderm dysfunction, has so far prevented the use of Gata6 Ϫ/Ϫ embryos for any analyses of the role of GATA6 during liver development. However, extraembryonic endoderm deficiencies can be rescued by generating embryos from embryonic stem (ES) cells by using tetraploid embryo complementation (12, 22) . We therefore attempted to address whether GATA6 is required for hepatogenesis by generating embryos from Gata6 Ϫ/Ϫ ES cells by the tetraploid embryo complementation approach. We found that Gata6 Ϫ/Ϫ ES cellderived embryos survive until E10.5, definitively demonstrating that embryonic lethality in GATA6-knockout embryos is a consequence of loss of GATA6 function in the extraembryonic endoderm as suggested previously (20, 27) . Analyses of the developing liver in these embryos show that GATA6 is dispensable for hepatic specification but essential for liver bud expansion and for normal expression of hepatic mRNAs within the nascent hepatoblasts. We also examined heart, septum transversum mesenchyme, and vascular development in
Gata6
Ϫ/Ϫ ES cell-derived embryos because they are the source of paracrine signals that are necessary for liver development. In contrast to the liver, however, we found that development of these tissues is not significantly affected by the absence of GATA6.
RESULTS

Gata6
؊/؊ ES cell-derived embryos complete gastrulation.
Development of Gata6
Ϫ/Ϫ embryos is blocked during gastrulation, and the embryos are unable to generate a fully differentiated extraembryonic endoderm (20, 27) . In addition, they fail to express mRNAs normally present in this endoderm including Hnf4 (27) . These data suggest that the early embryonic lethality associated with loss of GATA6 is a consequence of defective extraembryonic endoderm function, as has previously been demonstrated for Hnf4 Ϫ/Ϫ embryos (12) . Tetraploid embryo complementation has been used successfully to generate embryos from ES cells and to circumvent deficiencies in the extraembryonic endoderm function (12, 29) . In this approach, tetraploid embryos contribute cells to the extraembryonic endoderm while the fetus is derived solely from ES cells (30) . We therefore used this procedure to test whether the gastrulation arrest associated with the GATA6-null phenotype was due to extraembryonic endoderm defects as suggested by the analyses of Gata6-knockout embryos (20, 27) . A Gata6 Ϫ/Ϫ allele was generated in R1 ES cells according to the same strategy used to produce Gata6-knockout mice (27) , and Gata6 Ϫ/Ϫ cells were selected by growth of Gata6 ϩ/Ϫ cells in a high concentration of G418 (Fig. 1A) (28) . The genotype of all ES cells used in this study was confirmed by Southern blot analyses of genomic DNA (Fig. 1B) . As presented in Fig. 2 , post-gastrulation-stage E9.5 and E10.5 embryos could be produced from both control Gata6 ϩ/Ϫ (n ϭ 160) and experimental Gata6 Ϫ/Ϫ (n ϭ 180) ES cells, and embryos of both genotypes exhibited characteristics of normal developmental patterning ( Fig. 2A) Ϫ/Ϫ ES cell-derived embryos could be recovered was E10.5. While rescued Gata6 Ϫ/Ϫ embryos had clearly progressed through gastrulation, they were consistently smaller than control embryos ( Fig. 2A) . However, although they were relatively diminutive, the rate of development was indistinguishable between control and experimental embryos; somite number, appearance of limb buds, heart looping, and neural tube closure were the same between Gata6 ϩ/Ϫ and Gata6
ES cell-derived embryos isolated at E9.5 and E10.5. The cause of death or why Gata6 Ϫ/Ϫ ES cell-derived embryos are smaller has not been established. However, the extent of cell proliferation, determined by anti-phosphohistone H3 immunohistochemistry, was similar between Gata6 ϩ/Ϫ and Gata6 Ϫ/Ϫ ES cell-derived embryos at E9.5 (data not shown). In addition, the level of apoptotic cell death, determined by terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL), was also generally similar between control and mutant embryos (data not shown). In some GATA6-null embryos (three of five) there appeared to be a qualitative increase in TUNEL positive staining around the region of the presumptive liver bud compared to control embryos; however, this increase in TUNEL staining was variable, and we were unable to generate reproducible quantitative results. The finding that E10.5 embryos can routinely be generated from Gata6 Ϫ/Ϫ ES cells by tetraploid embryo complementation while GATA6-knockout embryos arrest during gastrulation definitively demonstrates that GATA6 expression is required in the extraembryonic endoderm to maintain an environment that supports gastrulation of the epiblast.
Development of the liver is blocked at E9.5 in Gata6 ؊/؊ ES cell-derived embryos. To determine whether GATA6 was required for development of the liver, we compared formation of the liver bud in histological sections of embryos at E9.5 and E10.5 that were generated from Gata6 ϩ/Ϫ or Gata6 Ϫ/Ϫ ES cells. All analyses were performed on embryos with similar numbers of somites to ensure that they were at equivalent developmental stages-the appearance of new somite pairs occurs approximately every 2 h in the mouse and allows highresolution timing of the developmental stage of embryos between E8.5 and E10.5. Figures 3A and C show that in control embryos the liver bud could easily be identified by E9.5 as a distinct outgrowth of the ventral foregut and, by E10.5, that hepatoblasts had delaminated from the primary liver bud and had migrated into the surrounding septum transversum mesenchyme. In contrast to controls, development of the liver in Gata6 Ϫ/Ϫ ES cell-derived embryos was severely perturbed. At E9.5, the liver bud consisted of a small rudimentary outgrowth of endoderm that had failed to expand by E10.5 ( Fig. 3B and  D) . Indeed, at E10.5, the liver bud was virtually indiscernible and there was no indication that the hepatoblasts had delaminated from the foregut.
These data suggested that there was a failure in the ability of the ventral endoderm to follow a normal hepatic developmental program. To address this directly, control and mutant embryos were stained for expression of characteristic markers of hepatic development. Figures 3E to H show that in situ hybridization analyses identified Alb1 mRNA within the developing liver of control embryos at E9.5 and E10.5 while in (16, 27) . As shown in Fig. 3I , HNF4 protein can be identified, by immunohistochemistry, in the nucleus of endodermal cells within the liver bud at E9.5. In Gata6 Ϫ/Ϫ embryos, however, although HNF4 can be identified in the visceral endoderm that acts as a positive control for antibody staining, no expression of HNF4 is found within the liver bud (Fig. 3J) .
Immediately following inductive signaling from surrounding tissues, the nascent hepatic cells initiate the process of differentiation. The onset of differentiation is rapid, and levels of hepatic mRNAs increase quickly, which presumably reflects commitment of the endoderm to a hepatic fate. Radioactive in situ hybridization, shown in Fig. 3K and M, shows that expression of Hex mRNA, which encodes a homeobox transcription factor essential for liver development, increases significantly between 20 and 23 somites in control E9.5 embryos (1, 19, 23) . In contrast, although Hex mRNA could be detected in Gata6
ES cell-derived embryos, the level was lower than that seen in controls, and moreover, between 20 and 23 somites Hex mRNA levels failed to increase in the absence of GATA6 ( Fig.  3L and N) . The fact that albumin and HNF4 were undetectable and that Hex mRNAs failed to increase in GATA6-null embryos demonstrates that GATA6 is required for the liver bud to mature and commit to a normal hepatic developmental program.
Hepatic specification occurs in Gata6 ؊/؊ ventral endoderm. The finding that Hex mRNA was present in the endoderm of Gata6 Ϫ/Ϫ embryos suggested that hepatic development had been induced within the ventral foregut. However, Hex mRNA is also expressed in the developing ventral pancreas, and so it seemed possible that the identification of Hex transcripts reflected development of the pancreas rather than liver. To definitively address whether hepatic specification had occurred in the absence of GATA6, we determined the extent of liver gene expression in ventral endoderm isolated from experimental and control E8.0 embryos containing six to eight somite pairs by RT-PCR. It is at this developmental stage that inductive cues acting on the endoderm specify hepatic cell fate (15) . Figure 4A shows that, as expected, Gata6 mRNA could be detected by RT-PCR in control ventral endoderm but was not detected in Gata6 Ϫ/Ϫ endoderm. Importantly, this result confirmed the absence of any GATA6-positive tetraploid embryoderived extraembryonic endoderm, which could potentially confound the analysis. Examination of steady-state levels of mRNAs encoding alpha-fetoprotein (Afp), albumin, HNF4, retinol binding protein (Rbp4), and transthyretin (Ttr), all of which are expressed in hepatoblasts, revealed that all were identified at comparable levels between control and Gata6 Given the clear absence of liver development at E9.5, the finding that expression of hepatic mRNAs within the ventral endoderm during the earliest stages of liver development (E8.5) was unaffected by loss of GATA6 seemed surprising. GATA factors, however, have similar DNA binding characteristics, and both GATA6 and GATA4 are expressed in endoderm-derived tissues, suggesting that they may functionally overlap (26, 31) . We therefore tested whether GATA4 was present in the ventral endoderm of embryos lacking GATA6 during hepatic specification. Figure 4B shows that GATA4 was indeed detected by immunohistochemistry in the presumptive hepatic ventral endoderm of both control and Gata6 Ϫ/Ϫ E8.5 ES cell-derived embryos containing 8 to 10 somites, suggesting that GATA4 has the potential to compensate for loss of GATA6 during hepatic specification.
GATA4 is transiently expressed in the early ventral endoderm and may complement loss of GATA6 during hepatic specification. If GATA4 and GATA6 have redundant roles in controlling liver gene expression during hepatic specification, it raises the question of why GATA4 is apparently unable to compensate for loss of GATA6 during later stages of hepatic development at E9.5 when the liver bud is expanding. With this in mind we examined expression of GATA4 and GATA6 in embryos containing 12 somites (E8.5), which had just completed hepatic specification, and in embryos containing 25 somites, in which hepatoblasts were migrating from the expanding liver bud. Figures 5A, C , E, G, and I show that, by 12 somites, GATA4 and -6 continue to be expressed in the specified hepatic endoderm of the liver bud as well as in the surrounding septum transversum mesenchyme. By 25 somites Gata6 mRNA was identified in the expanding hepatoblast cells, although at levels lower than those found in the septum transversum (Fig. 5B, D, and F) . This is consistent with previously published immunostaining data that show GATA6 protein also present in hepatoblasts of E14.5 livers (31). However, strikingly and in contrast to Gata6, GATA4 expression is abruptly extinguished in hepatoblasts as the cells delaminate from the specified hepatic endoderm coincident with the stage at which loss of GATA6 results in a hepatic phenotype (Fig.  5H and J) . This low to undetectable expression of GATA4 in hepatic parenchymal cells is also seen in adult livers. Figures 5K and L show that expression of GATA4 is most predominant in the endothelial cells surrounding the sinusoidal capillaries and large veins of the adult liver and in contrast is difficult to detect by immunohistochemistry in the hepatocytes. In situ hybridization studies showed that Gata4 mRNA was also undetectable in hepatoblasts in embryos at E9.5 (data not shown), suggesting that regulation was likely at the level of transcription. This dynamic expression of GATA4 in the early ventral endoderm is consistent with the proposal that GATA4 and GATA6 have redundant functions during hepatic specification but that only GATA6 is available to control expansion of the liver bud and commitment of hepatoblasts to express the normal profile of hepatic mRNAs.
GATA6 is dispensable for early development of the vasculature, septum transversum, and heart. A combination of genetic and molecular analyses has identified the developing heart, septum transversum mesenchyme, and vascular tissue as sources of signals required for specification and expansion of (21) . Many of these tissues also express GATA6, raising the possibility that the block in development of the liver in the absence of GATA6 could be caused by defective development of these nonhepatic tissues.
Figures 6A to D show immunohistochemical staining of control and Gata6 Ϫ/Ϫ E9.5 ES cell-derived embryos for PECAM, which is expressed in endothelial cells, and for GATA4, which is highly expressed in the septum transversum mesenchyme at the level of the liver bud. Both endothelial cells and septum transversum mesenchyme were seen to surround the hepatic bud regardless of GATA6's presence or absence. The finding that septum transversum mesenchyme was still present in the absence of GATA6 was interesting given that we had previously shown that Gata4 Ϫ/Ϫ embryos fail to form septum transversum mesenchyme as well as the related proepicardium (42) .
It has also been proposed that the GATA factors have crucial roles in controlling cardiac development (32) . Since car- FIG. 5 . Expression of GATA4 but not GATA6 is extinguished in migrating hepatoblasts. Embryos containing 12 (A, C, E, G, and I) or 25 (B, D, F, H, and J) somite pairs and adult livers (K and L) were isolated and processed for in situ hybridization to detect Gata6 mRNA (A to F) or for immunohistochemistry to detect GATA4 protein (G to L). Both GATA4 protein (brown nuclear staining; G and I) and Gata6 mRNA (A, C, and E) can be detected in the septum transversum mesenchyme (arrowheads) and liver bud (arrows) of 12-somite-pair embryos. At 25 somite pairs, Gata6 mRNA and GATA4 protein were detected in septum transversum mesenchyme (arrowheads; B, D, F, H, and J). In the liver bud (arrows; B, D, F, H, and J), however, the presence of Gata6 mRNA could be identified but GATA4 protein was undetectable. GATA4 protein was also detected predominantly in the endothelial cells (arrows) but not in hepatocytes (arrowheads) of adult livers (K and L). Panels E, F, I, J, and L show high-resolution images of boxed areas in panels C, D, G, H, and K, respectively. Both bright-field (A and B) and corresponding dark-field (C to F) images of Gata6 in situ hybridization analyses are presented. The presence of mRNA can be detected as bright silver grains in dark-field images; note the absence of staining in neural tubes (asterisks).
VOL. 25, 2005 GATA6 IN LIVER DEVELOPMENT 2627 diogenesis is essential for liver development, we determined whether development of the heart was affected by loss of GATA6. Figures 6E and F show hematoxylin-and eosinstained sections through the cardiac region of E9.5 control and Gata6 Ϫ/Ϫ ES cell-derived embryos. Both embryos appeared to have developed comparably, containing differentiated cardiomyocytes and endocardial cells. In a minority of cases, the extent of ventricular trabeculation was subtly reduced in the absence of GATA6; however, many Gata6 Ϫ/Ϫ ES cell-derived embryos appeared normal in this regard. The role of GATA factors in controlling cardiac gene expression has been studied intensely, and so we compared steady-state levels of several cardiomyocyte mRNAs by RT-PCR in hearts isolated from E9.5 embryos. As shown in Fig. 6I , expression of all cardiac mRNAs was similar in both control and Gata6 Ϫ/Ϫ ES cellderived hearts. Importantly, these mRNAs included those encoding Fgf1, Bmp2, and Bmp4, which have previously been shown to regulate development of the liver (17, 40) . The observation that cardiac gene expression was unaffected by loss of GATA6 could be due to maintenance of GATA4 expression in the Gata6 Ϫ/Ϫ cardiomyocytes. In support of GATA4 and GATA6 having redundant functions in the heart, GATA4 protein could indeed be detected in Gata6 Ϫ/Ϫ cardiomyocytes by immunohistochemistry, and Gata4 mRNA was identified in GATA6-null hearts by RT-PCR (Fig. 6G to I ).
DISCUSSION
Our production of post-gastrulation-stage embryos from Gata6 Ϫ/Ϫ ES cells, through tetraploid embryo complementation, definitively establishes that GATA6-knockout mice arrest during early embryonic development due to defects in ex- FIG. 6 . GATA6 is dispensable for early development of the heart, septum transversum meschyme, and vasculature. (A and B) Immunohistochemistry (brown staining) identifies PECAM-positive endothelial cells (e; arrows) surrounding the presumptive hepatic endoderm in both control and GATA6-null embryos at E9.5. (C and D) Septum transversum mesenchyme that expresses GATA4 can be identified surrounding the presumptive hepatic bud (arrow) in both Gata6 ϩ/Ϫ and Gata6 Ϫ/Ϫ E9.5 embryos by immunohistochemistry. (E to H) Hematoxylin-and eosinstained sections of Gata6 ϩ/Ϫ and Gata6 Ϫ/Ϫ fetal hearts at E9.5 finds no substantive differences in the morphology of endocardium or myocardium, which both express GATA4 protein as determined by immunohistochemistry (brown nuclear staining) (G and H). l, liver; s, septum transversion; a, atrium; v, ventricle. (20, 27) . A direct role for GATA6 acting as a regulator of extraembryonic endoderm development is also supported by loss-of-function studies of F9 embryonal carcinoma cells. In these experiments, the ability of F9 cells to form parietal endoderm in culture was suppressed when expression of GATA4 and GATA6 was simultaneously reduced using a short interfering RNA approach (14) . In addition, forced expression of GATA6 in ES cells induced these pluripotent cells to adopt an extraembryonic endoderm fate (13) . Together these results convincingly argue that GATA6 is a central regulator of extraembryonic endoderm differentiation. The availability of Gata6 Ϫ/Ϫ embryos that develop to E10.5 has also allowed us to demonstrate an essential role for GATA6 in controlling development of the mammalian liver. Although analysis of cell-type-specific knockouts of GATA6 will be necessary to definitively establish whether this factor acts cell autonomously during hepatogenesis, the observation that development of the heart, septum transversum, and embryonic vasculature appears relatively normal in Gata6 Ϫ/Ϫ embryos is consistent with GATA6 acting within the endoderm. Molecular and biochemical studies also support a cell-autonomous role for GATA factors in controlling liver development. Analyses of the Albumin gene's transcriptional regulatory elements have uncovered several transcription factors that appear to have roles in hepatic development (2, 15) . Of these factors, FoxA and GATA4 have been shown to interact with the Albumin enhancer in pluripotent definitive endoderm prior to the onset of Albumin gene expression and hepatic specification (15) . GATA4 and FoxA are unusual in that they can recognize their respective binding sites and form stable complexes in the context of compacted chromatin, which is normally recalcitrant to transcription factor binding (5, 7) . Importantly, binding of either FoxA or GATA4 opens compacted chromatin, and FoxA appears to have the capacity to reposition nucleosomes around the Albumin enhancer (5, 7). Based on these observations, it has been proposed that FoxA and GATA4 may act as potentiators of endodermal differentiation (44) . In this scheme, binding of these factors would remodel local areas of chromatin around the transcriptional regulatory elements of liver genes in the pluripotent endoderm, rendering them capable of binding transcriptional activators. This would maintain these genes in a competent but inactive state. If transcriptional activators were induced in response to inductive signals, they would then have access to the transcriptionally competent genes and initiate differentiation through activation of gene expression. Most of the studies that have led to this model have focused on GATA4 as the factor that acts in conjunction with FoxA to mediate hepatic competency of the endoderm (5-7). However, GATA binding sites can be recognized by GATA4, -5, and -6, suggesting that any of these could potentially act as pioneer factors.
Our data show that, as development proceeds, GATA6 alone is necessary for expansion of the liver bud and commitment of the endoderm to a hepatic cell fate. However, based on the finding that hepatic mRNA expression is unaltered in the absence of GATA6 in E8.5 embryos containing six to eight somites, hepatic specification of Gata6 Ϫ/Ϫ ventral endoderm appears to be intact. This may seem surprising given the compelling molecular evidence that supports a role for the GATA factors in regulating competency and, as a consequence, hepatic specification. However, examination of the expression of GATA4 within the endoderm of both wild-type and Gata6 Ϫ/Ϫ embryos offers a possible explanation of why GATA6 is dispensable for hepatic specification. We have demonstrated that GATA4 can be detected in the ventral endoderm prior to specification of the hepatic lineage. This expression continues within the presumptive nascent hepatic cells until the 12-to 14-somite stage of development (ϳE9.0). However, after this developmental time point GATA4 is rapidly lost from the cells within the nascent hepatic endoderm as the liver bud expands, although expression remains within dorsal domains of the foregut. In contrast to GATA4, Gata6 mRNA can be detected within the presumptive hepatic endoderm throughout these early stages of hepatogenesis. Based on these analyses we speculate that GATA4 compensates for loss of GATA6 during hepatic specification but that GATA6 alone is present to control subsequent stages of hepatic development. These results also suggest that GATA factors not only act during competency and specification stages but continue to be required as the liver bud is expanding. These proposals may ultimately be answered by the generation of embryos lacking both GATA4 and GATA6.
In addition to regulating development of the liver, GATA6 has also been implicated in heart development (32). Our studies of rescued GATA6-null embryos revealed at most only subtle changes in cardiac morphology; in some embryos formation of trabeculae within the developing ventricular regions appeared to be slightly reduced compared to controls. Although these data show that GATA6 is dispensable for early heart formation, it is possible that GATA6 is required for some physiological aspects of fetal cardiovascular function, which could conceivably explain the relatively small size of GATA6-null embryos. GATA4 is also expressed in the developing heart, and we have previously reported that GATA4-null embryos have an extremely thin ventricular myocardium and complete absence of the proepicardium (42). This did not appear to be the case for Gata6 Ϫ/Ϫ ES cell-derived embryos in which development of both proepicardium and myocardium was generally indistinguishable from control embryos. In addition, as was the case for Gata4 Ϫ/Ϫ embryos, GATA6-null embryos presented no alteration in cardiac gene expression, including expression of GATA4. Comparing the phenotypes presented by Gata4 Ϫ/Ϫ and Gata6 Ϫ/Ϫ ES cell-derived embryos, it is clear that the relationship between GATA4, GATA6, and their regulation of development is complex; in some cases, for example in hepatic specification and cardiac gene expression, there appears to be redundancy in function between GATA4 and GATA6, while in others, for example in development of the septum transversum and proepicardium, one factor appears to have a dominant role. Whether these factors act in a redundant or nonredundant manner may be explained by subtle differences in the timing of expression of the two factors in a given tissue during development or by differences in the binding of GATA4 and GATA6 to specific partners, such as Fog proteins and other coactivators. At the moment these issues are difficult to address; however, they may be resolved in the future by the availability of conditional alleles or by the use of specific short interfering RNAs.
In summary, we have demonstrated that providing Gata6 embryos with a wild-type extraembryonic endoderm allows these embryos to proceed through gastrulation. Examination of these rescued Gata6 Ϫ/Ϫ embryos reveals that, although they are smaller, development of many tissues occurs normally, with the exception of the liver, which arrests shortly after formation of the primary hepatic bud. While several transcription factors have been shown to influence hepatocyte differentiation and maturation of the liver, GATA6 can now be classified as one of a very few that are essential for the earliest stages of hepatic development. The future challenges that arise from this study clearly include defining the molecular mechanisms through which GATA6 controls development of the hepatic primordium.
